Total planned funding: $1,111,733,300
Clear active filters
Not Available
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
South Africa | $247,679,908 |
Kenya | $222,255,818 |
Tanzania | $114,325,813 |
Uganda | $100,023,872 |
Nigeria | $76,366,562 |
Ethiopia | $64,529,898 |
Mozambique | $47,692,919 |
Zimbabwe | $44,600,767 |
Zambia | $34,050,497 |
Botswana | $25,846,419 |
Malawi | $21,828,675 |
Vietnam | $13,500,515 |
Cameroon | $11,701,984 |
Haiti | $11,350,000 |
Namibia | $10,748,324 |
Lesotho | $10,346,279 |
Democratic Republic of the Congo | $9,949,794 |
Côte d'Ivoire | $9,471,378 |
Rwanda | $8,768,602 |
Cambodia | $5,845,500 |
South Sudan | $5,699,377 |
Eswatini | $5,584,149 |
Ukraine | $3,808,309 |
Dominican Republic | $1,776,000 |
Burundi | $1,510,929 |
Ghana | $1,476,612 |
China | $488,000 |
Thailand | $472,000 |
Guyana | $34,400 |
Russia | $0 |
Indonesia | $0 |
Program Areas
Treatment | $495,922,722 |
Care | $239,298,392 |
Prevention | $177,432,194 |
Testing | $100,172,811 |
Governance and Systems | $94,769,235 |
Budget Codes
HTXS: Treatment: Adult Treatment | $301,581,307 |
HTXD: Treatment: ARV Drugs | $164,835,925 |
HVCT: Testing: HIV Testing and Counseling | $100,172,811 |
HBHC: Care: Adult Care and Support | $90,884,305 |
HKID: Care: Orphans and Vulnerable Children | $88,431,414 |
HVOP: Sexual Prevention: Other Sexual Prevention | $55,811,740 |
HVSI: Strategic Information | $50,810,018 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $47,274,861 |
HVTB: Care: TB/HIV | $44,841,740 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $42,873,263 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $30,552,281 |
PDTX: Treatment: Pediatric Treatment | $29,505,490 |
OHSS: Health Systems Strengthening | $27,105,216 |
HLAB: Laboratory Infrastructure | $16,854,001 |
PDCS: Care: Pediatric Care and Support | $15,140,933 |
HMBL: Biomedical Prevention: Blood Safety | $645,000 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $219,000 |
HMIN: Biomedical Prevention: Injection Safety | $56,049 |